KBC Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.2M Sell
115,899
-703
-0.6% -$209K 0.09% 202
2025
Q4
$31.8M Buy
116,602
+16,227
+16% +$4.41M 0.07% 206
2025
Q3
$27.1M Buy
100,375
+2,583
+3% +$703K 0.07% 230
2025
Q2
$27M Buy
97,792
+13,563
+16% +$3.69M 0.07% 236
2025
Q1
$22.3M Sell
84,229
-6,647
-7% -$1.64M 0.07% 259
2024
Q4
$21.1M Sell
90,876
-20,619
-18% -$4.74M 0.06% 275
2024
Q3
$24.6M Buy
111,495
+29,114
+35% +$6.02M 0.07% 237
2024
Q2
$16.2M Buy
82,381
+5,000
+6% +$1.03M 0.05% 274
2024
Q1
$16.7M Sell
77,381
-14,810
-16% -$3.11M 0.05% 268
2023
Q4
$19.4M Buy
92,191
+23,681
+35% +$5.05M 0.07% 260
2023
Q3
$13.7M Sell
68,510
-36,295
-35% -$7.21M 0.06% 292
2023
Q2
$19.4M Sell
104,805
-132,471
-56% -$24.5M 0.08% 227
2023
Q1
$45.4M Buy
237,276
+17,637
+8% +$3.19M 0.19% 112
2022
Q4
$36.9M Buy
219,639
+111,056
+102% +$19.3M 0.18% 126
2022
Q3
$19.2M Sell
108,583
-14,269
-12% -$2.82M 0.1% 209
2022
Q2
$25.1M Sell
122,852
-12,977
-10% -$2.75M 0.13% 188
2022
Q1
$32.3M Sell
135,829
-28,051
-17% -$6.59M 0.13% 184
2021
Q4
$37.4M Buy
163,880
+68,958
+73% +$15.2M 0.12% 188
2021
Q3
$18.4M Sell
94,922
-90,358
-49% -$18.3M 0.07% 270
2021
Q2
$39.4M Buy
185,280
+94
+0.1% +$19.8K 0.07% 263
2021
Q1
$37.8M Buy
185,186
+14,190
+8% +$2.79M 0.08% 266
2020
Q4
$171M Sell
170,996
-82,108
-32% -$14M 0.07% 273
2020
Q3
$42.3M Buy
253,104
+123,036
+95% +$20.7M 0.13% 182
2020
Q2
$21.1M Buy
130,068
+58,135
+81% +$10.4M 0.07% 247
2020
Q1
$12.4M Buy
71,933
+5,979
+9% +$1.19M 0.1% 208
2019
Q4
$13.2M Buy
65,954
+105
+0.2% +$21.5K 0.08% 273
2019
Q3
$13.9M Buy
65,849
+31,690
+93% +$6.62M 0.1% 246
2019
Q2
$6.63M Sell
34,159
-24,258
-42% -$4.47M 0.05% 381
2019
Q1
$9.61M Sell
58,417
-50,070
-46% -$8.85M 0.08% 304
2018
Q4
$20.4M Sell
108,487
-86,181
-44% -$15.9M 0.23% 112
2018
Q3
$33.1M Sell
194,668
-24,004
-11% -$4.04M 0.25% 105
2018
Q2
$35.8M Buy
218,672
+32,434
+17% +$5.3M 0.31% 72
2018
Q1
$30.1M Sell
186,238
-74,065
-28% -$11.8M 0.28% 92
2017
Q4
$38M Buy
260,303
+32,727
+14% +$4.66M 0.32% 76
2017
Q3
$30.9M Buy
227,576
+5,240
+2% +$662K 0.28% 86
2017
Q2
$27.8M Buy
222,336
+55,247
+33% +$6.61M 0.27% 99
2017
Q1
$19.9M Buy
167,089
+42,217
+34% +$5.08M 0.18% 142
2016
Q4
$14.4M Buy
124,872
+58,138
+87% +$6.47M 0.14% 176
2016
Q3
$6.97M Buy
66,734
+29,435
+79% +$3.07M 0.08% 272
2016
Q2
$3.63M Buy
37,299
+11,016
+42% +$1.04M 0.05% 384
2016
Q1
$2.52M Buy
26,283
+2,370
+10% +$216K 0.04% 439
2015
Q4
$2.17M Sell
23,913
-3,425
-13% -$322K 0.04% 451
2015
Q3
$2.54M Sell
27,338
-75,340
-73% -$7.16M 0.05% 391
2015
Q2
$9.55M Buy
102,678
+16,708
+19% +$1.56M 0.12% 209
2015
Q1
$8.14M Buy
85,970
+52,221
+155% +$4.84M 0.1% 233
2014
Q4
$2.99M Buy
33,749
+16,395
+94% +$1.39M 0.04% 485
2014
Q3
$1.39M Sell
17,354
-16,973
-49% -$1.28M 0.05% 425
2014
Q2
$2.44M Buy
34,327
+5,478
+19% +$386K 0.03% 548
2014
Q1
$2.14M Sell
28,849
-23,003
-44% -$1.74M 0.03% 486
2013
Q4
$4.07M Sell
51,852
-2,949
-5% -$231K 0.06% 351
2013
Q3
$4.05M Sell
54,801
-36,900
-40% -$2.72M 0.07% 352
2013
Q2
$6.96M Buy
+91,701
New +$6.02M 0.13% 204

Other funds holding CME

KBC Group's CME Position: Q1 2026 in Review

KBC Group reduced its CME Group (CME) stake by 0.6% in Q1 2026, selling an estimated $209K and leaving 115,899 shares worth $34.2M. The position accounts for 0.09% of the portfolio, ranked #202.

KBC Group first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $171M in Q4 2020. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • KBC Group held 115,899 shares of CME Group worth $34.2M as of Q1 2026.
  • KBC Group sold 703 CME Group shares in Q1 2026, an estimated $209K.
  • CME Group made up 0.09% of KBC Group's portfolio in Q1 2026, its #202 holding.
  • KBC Group first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's CME Group position peaked at $171M in Q4 2020.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.